Circulating MMP-2 and TIMP-2 levels may be associated with the mechanisms of cardiac remodeling in patients with hypertrophic cardiomyopathy.
These results suggest that changes in the release and activity of MMP-2 and TIMP-2 may be associated with the mechanisms responsible for cardiac remodeling in patients with HCM.
Noji et al. (Thu,) studied this question.